KR20070054764A - Manufacturing method of black rootlets of ginseng - Google Patents

Manufacturing method of black rootlets of ginseng Download PDF

Info

Publication number
KR20070054764A
KR20070054764A KR1020050112633A KR20050112633A KR20070054764A KR 20070054764 A KR20070054764 A KR 20070054764A KR 1020050112633 A KR1020050112633 A KR 1020050112633A KR 20050112633 A KR20050112633 A KR 20050112633A KR 20070054764 A KR20070054764 A KR 20070054764A
Authority
KR
South Korea
Prior art keywords
ginseng
weight
process steps
black
hours
Prior art date
Application number
KR1020050112633A
Other languages
Korean (ko)
Other versions
KR101234605B1 (en
KR101234605B9 (en
Inventor
최성근
Original Assignee
대동고려삼 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대동고려삼 주식회사 filed Critical 대동고려삼 주식회사
Priority to KR1020050112633A priority Critical patent/KR101234605B1/en
Priority to PCT/KR2006/001407 priority patent/WO2007061162A1/en
Publication of KR20070054764A publication Critical patent/KR20070054764A/en
Application granted granted Critical
Publication of KR101234605B1 publication Critical patent/KR101234605B1/en
Publication of KR101234605B9 publication Critical patent/KR101234605B9/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254Acanthopanax or Eleutherococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/344Codonopsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 흑진삼 제조방법 및 그를 이용하여 제조된 흑진삼에 관한 것으로, 보다 구체적으로는 용매에 황기 20중량%, 사삼 20중량%, 오가피 20중량%, 맥문동 17 중량%, 복령 16 중량% 및 건강 7 중량%를 넣고 가열농축한 농축액에 홍삼을 침윤시킨 후 증숙 및 건조를 9회 이상 반복하여 보다 많은 사포닌을 함유하는 흑진삼을 제조하는 방법 및 그를 이용하여 제조된 흑진삼에 관한 것이다.The present invention relates to a method for producing black ginseng and black ginseng prepared by using the same, more specifically, 20% by weight of sulfur, 20% by weight of ginseng, 20% by weight of Ogapi, 17% by weight of Macmundong, 16% by weight of Bokryeong and The present invention relates to a method for producing black ginseng containing more saponin by infiltrating red ginseng into a concentrated solution heated to 7% by weight, followed by steaming and drying at least 9 times, and a black ginseng prepared by using the same.

흑진삼, 증숙, 건조, 사포닌, 인삼 Black Ginseng, Steamed, Dried, Saponin, Ginseng

Description

흑진삼 제조방법 및 그를 이용하여 제조된 흑진삼{MANUFACTURING METHOD OF BLACK ROOTLETS OF GINSENG}Method of manufacturing black ginseng and black ginseng manufactured using the same {MANUFACTURING METHOD OF BLACK ROOTLETS OF GINSENG}

본 발명은 흑진삼 제조방법 및 그를 이용하여 제조된 흑진삼에 관한 것으로, 보다 구체적으로는 용매에 황기 20중량%, 사삼 20중량%, 오가피 20중량%, 맥문동 17 중량%, 복령 16 중량% 및 건강 7 중량%를 넣고 가열농축한 농축액에 홍삼을 침윤시킨 후 증숙 및 건조를 9회 이상 반복하여 보다 많은 사포닌을 함유하는 흑진삼을 제조하는 방법 및 그를 이용하여 제조된 흑진삼에 관한 것이다.The present invention relates to a method for producing black ginseng and black ginseng prepared by using the same, more specifically, 20% by weight of sulfur, 20% by weight of ginseng, 20% by weight of Ogapi, 17% by weight of Macmundong, 16% by weight of Bokryeong and The present invention relates to a method for producing black ginseng containing more saponin by infiltrating red ginseng into a concentrated solution heated to 7% by weight, followed by steaming and drying at least 9 times, and a black ginseng prepared by using the same.

고려인삼(Panax ginseng C.A. Meyer)은 옛날부터 한방 의학에서 최고의 영약으로 신비스러운 약효는 다른 생약의 추종을 불허하는 천하의 명초로 인식되어 왔다. 우리 선조들이 동양을 지배하는 최고의 무역상이 된 것도 인삼 및 홍삼의 신비한 효능 때문인 것으로 전하여지고 있을 정도이다. 홍삼 및 인삼의 연구가 가속화되고 국제 인삼 심포지움이 개최된 것은 홍삼의 우수성에 의한 결과로 볼 수 있다. 홍삼의 성분에는 탄수화물과 아미노산, 사포닌, 그리고 지방산으로서 스테아린산, 팔미틴산, 올레인산이 있고, 홍삼 특유의 향인 휘발성 물질은 파네센(Panacene)이라는 물질로 알려져 있다. 홍삼 사포닌은 홍삼 수용액을 흔들 때 지속적인 거품을 일으키는 식물성분을 말하는 것으로 홍삼의 약효에 관여하는 물질이라고 인식되고 있다. 인삼이나 홍삼은 전체 중량의 약 60%를 차지하는 중심부 몸통에서는 사포닌이 소량만 검출되고, 대부분의 사포닌은 잔뿌리, 외주피 및 피층에 존재하고 있는 것으로 알려져 있으며, 대형인삼은 소형인삼에 비하여 사포닌 함유 비율이 적고, 부위별 사포닌 함량은 주근부에서 1.9%, 그리고 측근부에서 4.8%가 함유되어 있음이 확인되고 있으며, 쓴맛이 강한 것은 사포닌 함량이 높은 것으로 효능도 높아서 치료 기능 또한 높은 것으로 알려지고 있다. 총 사포닌 함량으로 볼 때는 4년근은 2.84%, 6년근은 2.19로, 약 30%의 차이를 보이고 있으나 사포닌의 종류에 따른 함량은 4∼6년근에 들쭉날쭉하여 우열을 판단할 수는 없다.Korean ginseng (Panax ginseng C.A. Meyer) has long been recognized as the best medicine in herbal medicine, and the mysterious medicinal effect has been recognized as the origin of the world unmatched by other herbal medicines. It is said that our ancestors became the best traders in the East because of the mysterious effects of ginseng and red ginseng. Red ginseng and ginseng research accelerated and the international ginseng symposium was held due to the excellence of red ginseng. Red ginseng contains carbohydrates, amino acids, saponins, and fatty acids such as stearic acid, palmitic acid, and oleic acid, and the volatile substance unique to red ginseng is known as panacene. Red ginseng saponin refers to a plant component that causes continuous foaming when shaking red ginseng aqueous solution and is recognized as a substance that is involved in the efficacy of red ginseng. Ginseng and red ginseng are found in small amounts of saponin in the trunk, which accounts for about 60% of the total weight. Most saponins are known to be present in the roots, outer skin and cortex, and large ginseng contains saponin compared to small ginseng. It is confirmed that the content of saponin is less than 1.9% in the main root and 4.8% in the inner part, and the bitterness is high in saponin and high in efficacy. The total saponin content is 2.84% for 4 years and 2.19 for 6 years, showing a difference of about 30%. However, the content of saponins is jagged at 4 to 6 years, so it is not possible to determine the superiority.

현대의학에 의하여 증명된 인삼 및 홍삼의 효능은 항상성 효과, 안전무독, 저항력 증진작용, 내분비 조절작용, 혈압조절, 대사 촉진, 소염, 쇠약 회복, 능률조절, 신경안정, 수명연장, 혈관강화, 조혈작용, 건위, 강정, DNA 합성, 항암, 정자증진, 항당뇨, 성장촉진 등으로 만병을 다스리는 통치약으로 일컬어지고 있을 정도이다. 이와 같은 효능을 가진 인삼은 산지별, 연근별, 대소별, 형태별, 부위별, 등급별로 분류하고 상호간에 깊은 관계를 가지고 있다. 인삼은 의약품과 식품으로 구분하여 기능과 책임에 따라 분류하며 치료와 예방이라는 목적으로 사용할 때는 약으로, 또 조건이 완화된 가공식품으로는 인삼차, 인삼주, 인삼과자 등의 식품 또는 건강보조 식품으로 구분하여 관리되고 있다. 인삼의 가공 목적은 건조되지 아니한 수삼은 80∼85%에 해당하는 수분으로 장기 저장이 불가능하여 백삼 또는 홍삼 등으로 장기보존을 목적으로 가공되어 왔고 1894년 대한제국 탁지부에서 홍삼을 전 매법으로 보호한 바 있다.The efficacy of ginseng and red ginseng certified by modern medicine has homeostatic effects, safety toxic effects, resistance enhancement, endocrine control, blood pressure control, metabolism promotion, anti-inflammatory, weakness recovery, efficiency control, nerve stability, life extension, blood vessel strengthening, hematopoiesis It is said to be a ruling medicine that controls all diseases with action, health, strength, DNA synthesis, anti-cancer, sperm promotion, anti-diabetes, and growth promotion. Ginseng having such efficacy is classified by mountain, lotus root, small and large, form, part, grade, and has a deep relationship with each other. Ginseng is divided into medicines and foods and classified according to their function and responsibility.They are used as medicines for the purpose of treatment and prevention, and processed foods with relaxed conditions are classified as foods such as ginseng tea, ginseng wine, ginseng confectionery or health supplement foods. Are managed. For the purpose of processing ginseng, undried ginseng is 80 ~ 85% of moisture, which can not be stored for a long time, and has been processed for long-term preservation such as white or red ginseng. There is a bar.

홍삼차는 홍삼을 추출하고 농축하여 엑기스를 이용한 추출차, 분말을 이용한 분말차 등으로 구분하여 관리되어 왔다. 홍삼차의 대표적인 것은 추출 과립차로서 홍삼 추출액을 농축시켜 포도당 및 유당에 혼합하여 과립 성형시켜 건조시킨 것으로, 당류를 담체로 하여 과립 성형화한 것이어서 현대인의 당류 기피현상으로 인해 그 기호성이 점점 상실되어 가고 있다. 이러한 현실을 감안하여 고려 홍삼의 우수성과 국익을 위하여 당이 없는 홍삼 침출차의 발명에 착안하여, 시대가 요구하는 기능성 차를 발명하고자 하였다. 또한, 사포닌의 함량이 높게 함유하고 있으면서도 별다른 제조방법이 없어서 폐기되어 왔던 인삼의 잔뿌리를 이용하여 인삼차를 개발하고자 하는 것이 본 발명자가 발명에 착수하게 된 계기가 되었다. 일반 홍삼은 그 주근부나 미근부 등을 물에 끊여서는 사포닌을 100% 용출할 수가 없어서, 기존에는 에탄올로 용출해야만 했기 때문에, 일반인들이 쉽게 차를 만들어 먹기가 어려웠고, 그만큼 제조 비용이 높기 때문에 소비자가 구입하는 비용도 크게 비싸다는 문제점이 있었다.Red ginseng tea has been managed by extracting and concentrating red ginseng into extract tea using extract and powder tea using powder. Representative of red ginseng tea is extract granulated tea, which is concentrated red ginseng extract, mixed with glucose and lactose, granulated and dried, and granularly molded with sugar as a carrier, and its palatability is gradually lost due to the avoidance of sugars in modern people. have. Considering this reality, the inventors of the invention focused on the invention of red ginseng leaching tea without sugar for the sake of excellence and national interest of Korean red ginseng. In addition, the present inventors have attempted to develop a ginseng tea using the small roots of ginseng, which had been discarded due to the high content of saponin but no manufacturing method. In general, red ginseng can not elute 100% of saponin by cutting its roots and tails in water, so it has been difficult to make tea easily because ordinary people had to elute it with ethanol. There was a problem that the cost of purchasing is also very expensive.

본 발명에서 홍삼을 담그는 침윤제로 사용하는 약제 중에서 황기는 강장작용, 면역기능조절작용, 강심이뇨 작용, 혈압강하작용 및 소염작용이 있으며 몸을 보호하는 약제로서 신체허약, 자한, 종기, 지갈, 음식무미 및 식욕부진에 유효하고 여성들에게는 자궁출혈, 부인대하, 월경불순 및 산전산후 일절병에 유효하며 에이즈, 암, 종양과 같은 면역 결핍 질병에 효과가 있고 만성 폐질환에도 좋다. 사삼은 보증, 익기, 화담 및 지혜의 효능이 있으며 진해, 거담, 강장약으로서 감기나 폐질 환의 거담제, 강장 및 배농제로 사용한다. 맥문동은 양음윤폐, 청심제번 및 양위생진의 효능이 있으며 자강강장약, 진해, 거담, 강심, 혈당강하작용 및 항염증작용이 있다. 복령은 강장, 이뇨 및 진정에 효능이 있어 신장병, 방광염, 요도염에 이용되고 소화성 궤양, 근육경련, 갈증, 현훈, 정신불안, 실면증에 효과적이며 접촉성 피부염 억제작용이 있다. 건강은 위액 분비 촉진과 장관의 연동 작용을 활성화시키므로 소화를 돕고 구토를 가라앉히는 효과를 나타내며 혈관운동 충추, 호흡 증추와 심장 흥분 작용이 있어서 혈액순환을 촉진시키며 항염증 작용 및 진통 작용이 있고 항균 작용을 나타낸다.In the present invention, the drug used as an infiltrating agent to soak red ginseng has tonic action, immune function control action, cardiac diuresis action, blood pressure lowering action and anti-inflammatory action and body protection agent, body weakness, jahan, boil, jigal, food It is effective for tastelessness and anorexia, and is effective for women with uterine bleeding, gynecological disorders, menstrual irregularities and postpartum maternal disease. Samsam has the effect of guarantee, ripening, talk and wisdom. It is used as an expectorant, tonic and fertilizer for colds and lung diseases as antitussive, expectorant and tonic. McMoon-Dong has the efficacy of Yang Yin Yun Pung, Cheongshimjeung and Yang San Sengjin, and has Jagangang, Jinhae, sputum, cardiac, hypoglycemic action and anti-inflammatory action. Bokryeong is effective in tonic, diuretic and sedative, and is used for kidney disease, cystitis and urethritis. It is effective for peptic ulcer, muscle cramps, thirst, vertigo, mental anxiety and insomnia, and inhibits contact dermatitis. Health promotes secretion of gastric juice and activates the peristalsis of the intestinal tract, which helps digestion and calms vomiting. Indicates.

본 발명은 상기한 종래 기술의 문제점을 해소하기 위한 것으로서, 사포닌의 함량을 높게 함유하고 있는 홍삼을 가공하여 물에 끊여서 보다 많은 양의 사포닌을 용출시킬 수 있도록 한 흑진삼 제조방법을 제공하는 데 있다.The present invention is to solve the above problems of the prior art, and to provide a method for producing black ginseng that can be eluted in a larger amount of saponin by cutting off red ginseng containing a high content of saponin in water. .

본 발명은 물, 에탄올, 메탄올, 이소프로판올로 이루어진 그룹 중에서 선택되는 하나 이상의 용매에 황기 20중량%, 사삼 20중량%, 오가피 20중량%, 맥문동 17 중량%, 복령 16 중량% 및 건강 7 중량%를 넣고 60∼70℃로 3∼6시간 동안 1차 증숙시킨 후 135℃의 온도로 약 3∼6시간 동안 고압 증숙하고 가열농축하여 5 브릭스(Brix)의 농축액을 제조하는 1공정 단계; 상기 농축액에 홍삼을 담구어 하룻밤동안 침윤시킨 후 가마솥 증숙기에서 온도 60∼70℃로 3∼6시간 동안 1차 증숙시킨 후, 70∼75℃의 황토건조실에서 수분량이 28%에 도달할 때까지 건조시키는 2공정 단계; 상기 2공정 단계를 다시 4회에 걸쳐 반복하는 3공정 단계; 상기 3공정 단계를 완료한 흑진삼을 고압증숙기에서 135℃의 온도로 약 3∼6시간 동안 고압 증숙하고, 맥반석 열풍회전건조기에서 60∼70℃의 온도로 수분 25%까지 건조시키는 4공정 단계; 상기 4공정을 다시 4회에 걸쳐 반복하는 5공정 단계: 및 상기 5공정 단계를 완료한 흑진삼을 벌크건조기에서 최종 수분함량 14%로 건조하는 6공정 단계를 포함하는 것을 특징으로 하는 흑진삼의 제조방법에 관한 것이다.The present invention provides 20% by weight of sulfur, 20% by weight of ginseng, 20% by weight of Ogapi, 17% by weight of Macmundong, 16% by weight of Bokryeong and 7% by weight of at least one solvent selected from the group consisting of water, ethanol, methanol and isopropanol. First step of steaming for 3 to 6 hours at 60 to 70 ° C., and then steaming at high pressure for about 3 to 6 hours at a temperature of 135 ° C. and heating to prepare a concentrated solution of 5 Brix; After soaking red ginseng in the concentrate for 1 night and steaming for 1 to 3 hours at 60-70 ° C in a cauldron steamer until the water content reaches 28% in 70-75 ° C ocher drying room. Two process steps of drying; Three process steps of repeating the two process steps four times again; The black ginseng, which has completed the three process steps, is steamed at a high pressure steamer at a temperature of 135 ° C. for about 3 to 6 hours, and dried at 25 to 60% water at a temperature of 60 to 70 ° C. in an elvan rock hot air dryer. ; Five process steps of repeating the above four steps four times: and six process steps of drying the black ginseng, which has completed the five process steps, to a final moisture content of 14% in a bulk dryer. It relates to a manufacturing method.

이하, 본 발명에 따른 흑진삼 제조방법 및 그를 이용하여 제조된 흑진삼에 대해 상세히 설명한다. 본 발명의 주된 기술내용은 사포닌의 함량이 가장 높은 홈삼을 최적으로 가공하여 흑진삼을 제조함으로써, 일반인들이 흑진삼을 간단하게 물에 끊여도 높은 사포닌이 함유된 인삼차를 음용할 수 있도록 하는 것이다. Hereinafter, a method for preparing black ginseng and the black ginseng prepared by using the same according to the present invention will be described in detail. The main technical content of the present invention is to produce black ginseng by optimally processing the ginseng with the highest content of saponin, so that ordinary people can drink ginseng tea containing high saponin even if the black ginseng is simply cut off in water.

인삼은 몸통부에 해당하는 주근부와 잔뿌리에 해당하는 미근부로 구분되는데, 일반적으로 주근부보다 미근부에 사포닌의 함량이 높게 함유되어 있다. 인삼의 주근부는 가공처리후의 색도에 따라 백미삼, 홍미삼 및 흑진삼으로 구분될 수 있는데, 본 발명에 따라서 제조된 흑삼은 흑색을 띠기 때문에 흑진삼으로 명명하도록 하겠다. 본 발명에 따른 흑진삼은 홍삼을 가마솥 증숙기에서 60∼70℃로 3~6시간 동안 1차 증숙한 후, 70∼75℃의 온도로 맞추어 수분함량이 28%에 도달할 때까지 건조한다. 상기 흑진삼을 상기 제 1공정과 동일한 방법으로 다시 4회에 걸쳐 반복하여 제조한다. 총 5회에 걸쳐 제 1공정을 완료한 흑진삼을 고압증숙기에서 135℃의 온도로 약 3∼6시간 동안 고압 증숙하고, 맥반석 열풍회전건조기에서 60∼70℃에서 수분 25%까지 건조시키는 공정을 수행한다. 또한, 상기 공정에서 제조된 흑진 삼을 상기 제 2공정과 동일한 방법으로 다시 4회에 걸쳐 반복제조한다. 상기 공정으로 제조된 흑삼을 증숙 및 건조를 반복하여 제조하고 제조한 흑진삼을 벌크건조기에서 최종 수분함량 14%로 건조한 후, 이물질을 제거하여 완제품의 흑진삼을 제조한다.Ginseng is divided into the main root portion corresponding to the trunk and the tail root corresponding to the root root. Generally, the content of saponin is higher in the tail portion than the main root portion. The main root of ginseng may be divided into white and red ginseng and black ginseng according to the chromaticity after processing. The black ginseng prepared according to the present invention will be named black ginseng because it has black color. Black ginseng according to the present invention first steamed red ginseng at 60-70 ° C. for 3-6 hours in a cauldron steamer, and then dried at a temperature of 70-75 ° C. until the water content reaches 28%. The black ginseng is repeatedly produced four times in the same manner as in the first step. The black ginseng, which has completed the first step five times, is steamed at a high pressure steamer at a temperature of 135 ° C. for about 3 to 6 hours, and dried to 25% moisture at 60 to 70 ° C. in an ganbanite hot air rotary dryer. Do this. In addition, the black ginsam produced in the above process is repeatedly produced four times in the same manner as in the second process. The black ginseng prepared by the above process is repeatedly steamed and dried, and the prepared black ginseng is dried with a final moisture content of 14% in a bulk dryer, and then foreign matters are removed to prepare black ginseng.

실시예 1Example 1

물과 에탄올을 1: 1 동일한 중량비율로 혼합한 용매에 황기 20g, 사삼 20g, 오가피 20g, 맥문동 17g, 복령 16g 및 건강 7g을 넣고 60℃로 3시간 동안 1차 증숙시킨 후 135℃의 온도로 약 3시간 동안 고압 증숙하고 가열농축하여 5 브릭스(Brix)의 농축액을 제조하였다. 상기 농축액에 홍삼 100g을 담구어 하룻밤동안 침윤시킨 후 가마솥 증숙기에서 온도 60℃로 3시간 동안 1차 증숙시킨 후, 70℃의 황토건조실에서 수분량이 28%에 도달할 때까지 건조시켰다. 상기 공정 단계를 다시 4회에 걸쳐 반복하고 고압증숙기에서 135℃의 온도로 약 3시간 동안 고압 증숙하고, 맥반석 열풍회전건조기에서 60℃의 온도로 수분 25%까지 건조시켰다. 상기 공정을 다시 4회에 걸쳐 반복하고 벌크건조기에서 최종 수분함량 14%로 건조하여 흑진삼 90g을 제조하였다.In a solvent mixed with water and ethanol in the same weight ratio of 1: 1, 20 g of Astragalus, 20 g of Samsam, 20 g of Ogapi, 17 g of Bokyeong-dong, 16 g of Bokryeong, and 7 g of health were first steamed at 60 ° C. for 3 hours and then heated to 135 ° C. High pressure steaming and heat concentration for about 3 hours to prepare a 5 Brix concentrate. 100 g of red ginseng was soaked in the concentrate and infiltrated overnight, followed by primary steaming at a temperature of 60 ° C. for 3 hours in a cauldron steamer, and then dried until the amount of water reached 28% in an ocher drying chamber at 70 ° C. The process steps were repeated four more times and steamed at high pressure for about 3 hours at a temperature of 135 ° C. in a high pressure steamer, and dried at a temperature of 60 ° C. at a temperature of 60 ° C. in a ganbanite hot air rotary dryer. The process was repeated four more times and dried to a final moisture content of 14% in a bulk dryer to prepare 90 g of black ginseng.

실험예 1Experimental Example 1

본 발명의 방법으로 제조한 흑진삼을 중앙대학교 인삼산업연구소에 의뢰하여 사포닌의 함량을 분석하였다. Black ginseng prepared by the method of the present invention was commissioned by the ginseng industry research institute of Chung-Ang University to analyze the content of saponin.

◈ 실험 방법 ◈ Experiment Method

1. 구증  1. Guobi

Sample 100g(분말화)을 95% EtOH 2시간동안 2회 열추출 후 농축하여 식품공전법의 흑삼 성분법에 의한 전처리 후 HPLC 분석하였다. 시험결과는 표1에 나타났다.      100 g (powdered) of the sample was 95% EtOH for 2 hours after heat extraction and concentrated and analyzed by HPLC after pretreatment by the black ginseng component method of the food method. The test results are shown in Table 1.

2. 구증+주증3회  2. Guobi + 3rd Note

Sample 100g(분말화), 95% EtOH 2시간동안 2회 열 추출 후 농축하여 식품공전법의 흑삼 성분법에 의한 전처리 후 HPLC 분석하였다. 시험결과는 표2에 나타났다.     Sample 100g (powdered), 95% EtOH 2 hours after the heat extraction for 2 hours, concentrated and analyzed by HPLC after pretreatment by the black ginseng component method of the food method. The test results are shown in Table 2.

3. 주증4회  3. 4 times

Sample 100g(분말화), 95% EtOH 2시간동안 2회 열 추출 후 농축하여 식품공전법의 흑삼 성분법에 의한 전처리 후 HPLC 분석하였다. 시험결과는 표3에 나타났다.     Sample 100g (powdered), 95% EtOH 2 hours after the heat extraction for 2 hours, concentrated and analyzed by HPLC after pretreatment by the black ginseng component method of the food method. The test results are shown in Table 3.

◈ HPLC 분석 조건 ◈ HPLC analysis condition

1. Mobile Phase  1. Mobile Phase

Solvent A - ACN : Water : IPA = 80 : 5 : 15    Solvent A-ACN: Water: IPA = 80: 5: 15

Solvent B - ACN : Water : IPA = 67 : 21 : 12    Solvent B-ACN: Water: IPA = 67: 21: 12

2. Gradient  2. Gradient

TimeTime 00 2828 3535 4545 5050 5151 5757 5858 6565 %B% B 1010 8585 8080 7575 9090 100100 2525 1010 1010

3. Flow rate : 0.8 ㎎/㎖  3.Flow rate: 0.8 ㎎ / ㎖

4. Detector : ELSD 2000ES  4. Detector: ELSD 2000ES

5. Column : Prevail Carbohydrate ES column  5.Column: Prevail Carbohydrate ES column

표 1.Table 1.

시험항목Test Items 시험결과Test result 비고Remarks 조사포닌(w/w %)Irradiated Phonin (w / w%) 6.0516.051 식품공전법 처리Food Code Processing Ginsenoside-Rh2(w/w %)Ginsenoside-Rh 2 (w / w%) 0.1670.167 HPLC 분석HPLC analysis Ginsenoside-Rh1(w/w %)Ginsenoside-Rh 1 (w / w%) 0.0960.096 HPLC 분석HPLC analysis Ginsenoside-Rg2(w/w %)Ginsenoside-Rg 2 (w / w%) 0.0150.015 HPLC 분석HPLC analysis Ginsenoside-Rg3(w/w %)Ginsenoside-Rg 3 (w / w%) 0.1810.181 HPLC 분석HPLC analysis Ginsenoside-Rg1(w/w %)Ginsenoside-Rg 1 (w / w%) 0.1360.136 HPLC 분석HPLC analysis Ginsenoside-Rf(w/w %)Ginsenoside-Rf (w / w%) 0.0300.030 HPLC 분석HPLC analysis Ginsenoside-Re(w/w %)Ginsenoside-Re (w / w%) 00 HPLC 분석HPLC analysis Ginsenoside-Rd(w/w %)Ginsenoside-Rd (w / w%) 0.0090.009 HPLC 분석HPLC analysis Ginsenoside-Rc+Rb2(w/w %)Ginsenoside-Rc + Rb 2 (w / w%) 0.0080.008 HPLC 분석HPLC analysis Ginsenoside-Rb1(w/w %)Ginsenoside-Rb 1 (w / w%) 0.0450.045 HPLC 분석HPLC analysis

표 2.Table 2.

시험항목Test Items 시험결과Test result 비고Remarks 조사포닌(w/w %)Irradiated Phonin (w / w%) 4.7364.736 식품공전법 처리Food Code Processing Ginsenoside-Rh2(w/w %)Ginsenoside-Rh 2 (w / w%) 0.1150.115 HPLC 분석HPLC analysis Ginsenoside-Rh1(w/w %)Ginsenoside-Rh 1 (w / w%) 0.0580.058 HPLC 분석HPLC analysis Ginsenoside-Rg2(w/w %)Ginsenoside-Rg 2 (w / w%) 0.0090.009 HPLC 분석HPLC analysis Ginsenoside-Rg3(w/w %)Ginsenoside-Rg 3 (w / w%) 0.1090.109 HPLC 분석HPLC analysis Ginsenoside-Rg1(w/w %)Ginsenoside-Rg 1 (w / w%) 0.0240.024 HPLC 분석HPLC analysis Ginsenoside-Rf(w/w %)Ginsenoside-Rf (w / w%) 0.0190.019 HPLC 분석HPLC analysis Ginsenoside-Re(w/w %)Ginsenoside-Re (w / w%) 00 HPLC 분석HPLC analysis Ginsenoside-Rd(w/w %)Ginsenoside-Rd (w / w%) 0.0060.006 HPLC 분석HPLC analysis Ginsenoside-Rc+Rb2(w/w %)Ginsenoside-Rc + Rb 2 (w / w%) 0.0030.003 HPLC 분석HPLC analysis Ginsenoside-Rb1(w/w %)Ginsenoside-Rb 1 (w / w%) 0.0220.022 HPLC 분석HPLC analysis

표 3.Table 3.

시험항목Test Items 시험결과Test result 비고Remarks 조사포닌(w/w %)Irradiated Phonin (w / w%) 4.3474.347 식품공전법 처리Food Code Processing Ginsenoside-Rh2(w/w %)Ginsenoside-Rh 2 (w / w%) 0.1020.102 HPLC 분석HPLC analysis Ginsenoside-Rh1(w/w %)Ginsenoside-Rh 1 (w / w%) 0.1070.107 HPLC 분석HPLC analysis Ginsenoside-Rg2(w/w %)Ginsenoside-Rg 2 (w / w%) 0.0420.042 HPLC 분석HPLC analysis Ginsenoside-Rg3(w/w %)Ginsenoside-Rg 3 (w / w%) 0.3490.349 HPLC 분석HPLC analysis Ginsenoside-Rg1(w/w %)Ginsenoside-Rg 1 (w / w%) 0.0110.011 HPLC 분석HPLC analysis Ginsenoside-Rf(w/w %)Ginsenoside-Rf (w / w%) 0.0470.047 HPLC 분석HPLC analysis Ginsenoside-Re(w/w %)Ginsenoside-Re (w / w%) 0.0050.005 HPLC 분석HPLC analysis Ginsenoside-Rd(w/w %)Ginsenoside-Rd (w / w%) 0.0240.024 HPLC 분석HPLC analysis Ginsenoside-Rc+Rb2(w/w %)Ginsenoside-Rc + Rb 2 (w / w%) 0.0200.020 HPLC 분석HPLC analysis Ginsenoside-Rb1(w/w %)Ginsenoside-Rb 1 (w / w%) 0.1020.102 HPLC 분석HPLC analysis

실험예 2Experimental Example 2

본 발명의 방법으로 제조한 흑진삼의 효과를 확인하기 위하여 충청남도 금산의 동일지역에서 함께 재배한 4년생의 인삼을 같은 시기에 채취, 이를 원료삼으로 사용하였다. 하기 표 4에는 상기와 같은 제조방법에 의하여 제조한 본 발명에 따른 흑진삼과 홍삼근의 사포닌 성분을 비교한 결과가 기재되어 있다.In order to confirm the effect of black ginseng prepared by the method of the present invention, the four-year-old ginseng cultivated together in the same region of Geumsan, Chungcheongnam-do was collected at the same time, and used as raw ginseng. Table 4 below shows the results of comparing the saponin components of the black ginseng and red ginseng root according to the present invention prepared by the manufacturing method as described above.

표 4. 흑진삼과 홍삼근의 성분비교표Table 4. Composition of Black Ginseng and Red Ginseng Root

시험항목Test Items 시험결과Test result 비고Remarks 흑진삼Black Ginseng 홍삼근Red ginseng root 수분(%)moisture(%) 15.8215.82 13.8813.88 n-BuOH Extract(mg/g)n-BuOH Extract (mg / g) 42.7842.78 22.1022.10 Ginsenosides-Rg3(mg/g)Ginsenosides-Rg 3 (mg / g) 1.241.24 0.180.18 Ginsenosides-Rg2(mg/g)Ginsenosides-Rg 2 (mg / g) 1.201.20 0.080.08 Ginsenosides-Rg1(mg/g)Ginsenosides-Rg 1 (mg / g) 0.500.50 0.180.18 Ginsenosides-Rf(mg/g)Ginsenosides-Rf (mg / g) 0.500.50 0.220.22 Ginsenosides-Re(mg/g)Ginsenosides-Re (mg / g) 0.920.92 0.400.40 Ginsenosides-Rd(mg/g)Ginsenosides-Rd (mg / g) 1.021.02 0.260.26 Ginsenosides-Rc(mg/g)Ginsenosides-Rc (mg / g) 1.191.19 0.250.25 -Rb2(mg/g)-Rb 2 (mg / g) 0.980.98 0.190.19 -Rb1(mg/g)-Rb 1 (mg / g) 1.911.91 0.690.69 -Rh(mg/g)            -Rh (mg / g) 확인Confirm 확인Confirm

상기 표 4에 기재된 바와 같이, 본 발명에 따라 제조된 흑진삼의 사포닌 성 분들의 함량을 보면 홍삼근 보다도 모든 성분에서 크게 높게 나타남을 볼 수 있다. 본 발명에 따라 제조된 흑진삼은 상기의 성분들이 물에 끊였을 때에 거의 대분분이 용출되기 때문에, 그 약리적인 효과도 다른 제품들보다 월등히 높은 것이다.As shown in Table 4, the saponin content of the black ginseng prepared according to the present invention can be seen to be significantly higher in all components than the red ginseng root. Black ginseng prepared according to the present invention is almost eluted when the above components are suspended in water, the pharmacological effect is significantly higher than other products.

본 발명의 흑진삼 성분의 약리작용을 살펴보면 Ginsenosides-Rg3는 암세포전이 억제작용, 혈소판 응집억제 및 항혈전작용, 실험적 간 상해 억제작용, 혈관이완 작용, 항암제의 내성 억제작용을 하고, Ginsenosides-Rg2는 혈소판 응집억제, 항트롬빈, 선용활성화작용, 기억감퇴 개선, 평활근세포 증식억제작용, 아세칠콜린 유도, 카레콜아민 분비 억제 및 세포내 칼슘 유입 억제작용을 하고, Ginsenosides-Rg1는 면역기능 증강작용, 혈소판응집억제, 항트롬빈, 선용활성화 작용, 기억 및 학습기능증진작용, 코티코스테로이드 수용체 활성화 작용, 단백질합성 촉진작용, 항피로 작용, 항스트레스 작용, 중추 흥분작용, 혈관 확장작용 및 내인성 발열물질 등 유해자극 방어작용, 스트레스성 성행동장해 개선작용, 항신염 작용 및 신혈류량 증대작용, 신경세포 생존율 촉진작용, 콜레스테롤 대사 촉진작용, 항염증 작용, 간세포 증식 및 DNA 합성촉진, 간장해 보호작용, 부신피질자극 호르몬 분비 촉진작용을 하고, Ginsenosides-Rf는 통증억제 작용, 지질과산화 억제작용, 알코올 유도 뇌발육 장해 방어작용을 하고, Ginsenosides-Re는 부신피질 자극호르몬, 코티코스테론 분비촉진, 골수세포의 DNA, RNA, 단백질, 지질합성 촉진작용, 진통작용, 평할근 세포증식억제, 혈관 확장작용, 콜레스테롤 대사 촉진작용, 간 상해 보호작용, 항 고온스트레스 작용을 하고, Ginsenosides-Rd는 부신피질 자극호르몬, 코티코스테론 분비 촉진작용, mesanchyme 세포증식 억제를 하고, Ginsenosides-Rc는 진통작용, 코티코스테론 분비 촉진작용, PGI2 생성 촉진작용, 간, 혈청콜레스테롤, RNA 합성촉진작용, 골수세포 DNA, RNA, 단백질 및 지질합성 촉진작용, mesenchyme 세포증식억제 작용을 하고, Ginsenosides-Rb2는 당 및 지방대사 촉진, 항당뇨 작용, ACTHcAMP, epinephrine유도 지방분해 억제작용, 질소대사 평형 유지작용, 고콜레스테롤 저하 및 항동맥경화 작용, DNA, RNA, 부신피질 자극 호르몬, 코티코스테론 분비 촉진작용, 단백질, 지질합성 촉진작용, 암독소 호르몬의 길항작용, 평활근 세포 증식 억제작용, 종양혈과 stlstod 억제작용, 스트레스성 식욕 감퇴 개선, 항산화 활성물질 생성 촉진작용, 간조직의 ATP공급 활성화 작용, ATP함량 증가, 진통작용을 하고, Ginsenosides-Rb1는 중추억제 및 정신안정 작용, 중추성 섭식 억제작용, 공격성 행동억제, 진통작용, 항경련작용, 부신피질자극호르몬 및 코티코스테론 분비 촉진작용, 항불안작용, 콜레스테롤 생합성 촉진작용, 고콜레스테롤과 중성지방 및 유리지방산의 저하작용, 골수세포의 DNA, RNA, 단백질 및 지질합성 촉진작용, 단백질합성 촉진작용, 신경세포 생존 촉진작용, 아세칠 콜린 방출 촉진작용, 기억력 개선작용, 혈소판 응집 억제작용, 지질과산화 억제작용, 혈관확장작용, 콜레스테롤 대사 촉진작용, 항염증 작용, 간 상해 보호작용, 사염화탄소 유도, 간의 단백질 인산화 억제 및 세포내 칼슘축적 억제작용, 탐식기능 활성화 작용을 하며, Ginsenosides-Rh1는 실험적 간 상해 억제작용, 종양세포분화촉진, 혈소판 응집억제 및 선용활성화 작용 을 하고, Ginsenosides-Rh2는 암세포증식 억제작용, 암세포 재분화 유도 촉진작용, 암세포 침윤 억제작용, 종양증식 억제작용, 항암제의 항암활성 증대작용을 한다.Looking at the pharmacological action of the black ginseng component of the present invention Ginsenosides-Rg 3 inhibits cancer cell metastasis, inhibits platelet aggregation and antithrombotic action, experimental liver injury inhibitory action, vascular relaxation action, anti-cancer drug resistance, Ginsenosides-Rg 2 inhibits platelet aggregation, antithrombin, gland activation, memory loss, smooth muscle cell proliferation inhibition, acylcholine induction, currycolamine secretion and intracellular calcium influx, Ginsenosides-Rg 1 Enhancer, platelet aggregation inhibitory, antithrombin, glandular activation, memory and learning function, corticosteroid receptor activation, protein synthesis promotion, antifatigue, antistress, central excitability, vasodilation and endogenous fever Defense against harmful stimuli such as substances, improving stressful sexual behavior disorders, anti-nephritis and renal blood flow, promoting neuronal survival Ginsenosides-Rf inhibits pain, inhibits lipid peroxidation, alcohol-induced brain development, and promotes cholesterol metabolism, anti-inflammatory, hepatic cell proliferation and DNA synthesis, hepatic impairment protection, and corticosteroid secretion. Ginsenosides-Re acts as a defense against corticosteroids, corticosteroid secretion, bone marrow cell DNA, RNA, protein, lipid synthesis, analgesic activity, flat muscle cell proliferation inhibition, vasodilation, cholesterol metabolism Ginsenosides-Rd promotes adrenal cortical stimulating hormone, corticosteroid secretion, mesanchyme cell proliferation, Ginsenosides-Rc promotes analgesic and corticosteroid secretion Action, PGI 2 production promotion, liver, serum cholesterol, RNA synthesis promotion, bone marrow cell DNA, RNA, protein and lipid synthesis promotion, mesenchyme cell proliferation Ginsenosides-Rb 2 promotes glucose and fat metabolism, antidiabetic action, ACTHcAMP, epinephrine-induced lipolysis, nitrogen metabolism equilibrium, high cholesterol and anti-arteriosclerosis, DNA, RNA, adrenal cortex Stimulating hormone, stimulating corticosteroid secretion, stimulating protein, lipid synthesis, antagonism of cancer toxin hormone, inhibiting smooth muscle cell proliferation, inhibiting tumor blood and stlstod, improving stress appetite loss, promoting antioxidant active substance production, ATP supply activation of liver tissue, increased ATP content, analgesic action, Ginsenosides-Rb 1 is central and anti-stable, central feeding, inhibitory action, analgesic, anticonvulsant, adrenal cortex stimulating hormone And corticosterone secretion, anti-anxiety, cholesterol biosynthesis, high cholesterol and triglycerides and free fatty acids, bone marrow cells DNA, RNA, Promote protein and lipid synthesis, Promote protein synthesis, Promote nerve cell survival, Promote acetylcholine release, Improve memory, Inhibit platelet aggregation, Inhibit lipid peroxidation, Vasodilation, Promote cholesterol metabolism, Anti-inflammatory Action, protect liver injury, induce carbon tetrachloride, inhibit liver protein phosphorylation and inhibit intracellular calcium accumulation, activate phagocytosis. Ginsenosides-Rh 1 inhibits experimental liver injury, promotes tumor cell differentiation, inhibits platelet aggregation and uses Activation action, Ginsenosides-Rh 2 has the effect of inhibiting cancer cell proliferation, promoting the induction of cancer cell regeneration, inhibiting cancer cell invasion, inhibiting tumor proliferation, anticancer activity.

상기에 언급한 바와 같이, 본 발명의 흑진삼 제조방법에 따르면 용매에 황기 20중량%, 사삼 20중량%, 오가피 20중량%, 맥문동 17 중량%, 복령 16 중량% 및 건강 7 중량%를 넣고 가열농축한 농축액에 홍삼을 침윤시킨 후 증숙 및 건조를 9회 이상 반복하여 보다 많은 사포닌을 함유하는 흑진삼을 제조할 수 있으며, 그렇게 해서 제조된 흑진삼에는 다른 홍삼근 보다도 높은 함량의 사포닌을 함유할 수 있도록 한다. 한편, 상기에서는 본 발명의 바람직한 실시예들을 참조하여 설명하였지만, 해당 기술분야에서 통상의 지식을 가진 자라면 하기의 청구의 범위에 기재된 본 발명의 사상 및 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있음을 이해할 수 있을 것이다. As mentioned above, according to the method for producing black ginseng according to the present invention, 20% by weight of sulfuric acid, 20% by weight of Sasam ginseng, 20% by weight of Ogapi, 17% by weight of Macmundong, 16% by weight of Bokryeong, and 7% by weight of health are heated. After infiltrating red ginseng into the concentrated concentrate, steaming and drying can be repeated nine times or more to produce black ginseng containing more saponins, and the black ginseng thus prepared can contain a higher content of saponins than other red ginseng roots. Make sure On the other hand, while the above has been described with reference to the preferred embodiments of the present invention, those skilled in the art to which the present invention pertains without departing from the spirit and scope of the present invention described in the claims below It will be understood that modifications and changes can be made.

Claims (2)

물, 에탄올, 메탄올, 이소프로판올로 이루어진 그룹 중에서 선택되는 하나 이상의 용매에 황기 20중량%, 사삼 20중량%, 오가피 20중량%, 맥문동 17 중량%, 복령 16 중량% 및 건강 7 중량%를 넣고 60∼70℃에서 3∼6시간 동안 1차 증숙시킨 후 135℃에서 3∼6시간 동안 고압 증숙하고 가열농축하여 5 브릭스(Brix)의 농축액을 제조하는 1공정 단계; 상기 농축액에 홍삼을 담구어 하룻밤동안 침윤시킨 후 가마솥 증숙기에서 60∼70℃로 3∼6시간 동안 1차 증숙시킨 후, 70∼75℃의 황토건조실에서 수분량이 28%에 도달할 때까지 건조시키는 2공정 단계; 상기 2공정 단계를 다시 4회에 걸쳐 반복하는 3공정 단계; 상기 3공정 단계를 완료한 흑진삼을 고압증숙기에서 135℃로 3∼6시간 동안 고압 증숙하고, 맥반석 열풍회전건조기에서 60∼70℃로 수분 25%까지 건조시키는 4공정 단계; 상기 4공정을 다시 4회에 걸쳐 반복하는 5공정 단계: 및 상기 5공정 단계를 완료한 흑진삼을 벌크건조기에서 최종 수분함량 14%로 건조하는 6공정 단계를 포함하는 것을 특징으로 하는 흑진삼의 제조방법.20 to 20% by weight of sulfuric acid, 20% by weight of Sasam, 20% by weight of Ogapi, 17% by weight of McMoon-Dong, 16% by weight of Fuling, and 7% by weight of Health are added to at least one solvent selected from the group consisting of water, ethanol, methanol and isopropanol. First steaming at 70 ° C. for 3 to 6 hours, and then steaming at high pressure at 135 ° C. for 3 to 6 hours and heating to prepare a concentrated solution of 5 Brix; After soaking red ginseng in the concentrate for 1 night and steaming it first at 60-70 ° C. for 3-6 hours in a cauldron, it is dried until 70% water content reaches 28% in 70-75 ° C. ocher drying room. Two process steps to make; Three process steps of repeating the two process steps four times again; 4 process steps of steaming black ginseng, which has completed the three process steps, at high pressure steamer at 135 ° C. for 3 to 6 hours, and drying them to 25% moisture at 60 to 70 ° C. in an elvan hot air rotary dryer; Five process steps of repeating the above four steps four times: and six process steps of drying the black ginseng, which has completed the five process steps, to a final moisture content of 14% in a bulk dryer. Manufacturing method. 상기 제 1항의 제조방법에 따라 제조된 것을 특징으로 하는 흑진삼.Black ginseng, characterized in that prepared according to the method of claim 1.
KR1020050112633A 2005-11-24 2005-11-24 Manufacturing method of black rootlets of ginseng KR101234605B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020050112633A KR101234605B1 (en) 2005-11-24 2005-11-24 Manufacturing method of black rootlets of ginseng
PCT/KR2006/001407 WO2007061162A1 (en) 2005-11-24 2006-04-17 Black rootlets of ginseng and process for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050112633A KR101234605B1 (en) 2005-11-24 2005-11-24 Manufacturing method of black rootlets of ginseng

Publications (3)

Publication Number Publication Date
KR20070054764A true KR20070054764A (en) 2007-05-30
KR101234605B1 KR101234605B1 (en) 2013-02-22
KR101234605B9 KR101234605B9 (en) 2021-11-19

Family

ID=38067367

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020050112633A KR101234605B1 (en) 2005-11-24 2005-11-24 Manufacturing method of black rootlets of ginseng

Country Status (2)

Country Link
KR (1) KR101234605B1 (en)
WO (1) WO2007061162A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100864471B1 (en) * 2007-04-25 2008-10-20 김재경 A processed ginseng using extract of herb medicine and a producing method thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101593618B1 (en) * 2009-05-26 2016-02-15 (주)아모레퍼시픽 Composition for improving bioavailability of saponin
CN103404675A (en) * 2013-08-30 2013-11-27 黑龙江省新曙光刺五加生物科技开发有限公司 Acanthopanax senticosus tea for preventing flu and preparation method thereof
KR102411106B1 (en) * 2022-02-11 2022-06-22 대동고려삼 주식회사 Method for producing black ginseng concentrate with increased prosapogenin ginsenoside content using continuous steaming-drying technique and combined concentration technology

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3782122B2 (en) * 1994-04-11 2006-06-07 サンスター株式会社 Metabolism promoter for oral intake and food containing the same
MY124001A (en) * 1999-04-23 2006-06-30 E Excel Int Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice
KR20030012714A (en) * 2001-08-04 2003-02-12 양상철 a making method for growth food
KR20030081930A (en) * 2002-04-15 2003-10-22 이규환 A marking method of red ginseng jam used the red ginseng by main raw material and therefore red ginseng jam
KR100496418B1 (en) 2002-09-11 2005-06-28 한국파낙스제조(주) Manufacturing method of black rootlets of ginseng
KR20040063741A (en) * 2003-01-08 2004-07-14 김종호 This method and manufacturing of wild red-ginseng using wild ginseng
KR100543862B1 (en) 2005-08-01 2006-01-23 (주) 흑삼코리아 A black ginseng having excel content of active ingredient and the concentrate of black ginseng
KR100600795B1 (en) 2006-01-18 2006-07-19 (주) 흑삼코리아 A black ginseng having excel content of ginsenoside rg3 ingredient and the concentrate of black ginseng
KR100864471B1 (en) 2007-04-25 2008-10-20 김재경 A processed ginseng using extract of herb medicine and a producing method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100864471B1 (en) * 2007-04-25 2008-10-20 김재경 A processed ginseng using extract of herb medicine and a producing method thereof

Also Published As

Publication number Publication date
WO2007061162A1 (en) 2007-05-31
KR101234605B1 (en) 2013-02-22
KR101234605B9 (en) 2021-11-19

Similar Documents

Publication Publication Date Title
CN107467650B (en) Red date donkey-hide gelatin cake and preparation method thereof
KR100496418B1 (en) Manufacturing method of black rootlets of ginseng
CN104946453B (en) A kind of production method of health care medicinal wheat koji
CN103740566B (en) Rosa roxbunghii medicinal liquor and preparation method thereof
CN103610065A (en) Sea cucumber and maca composition and preparation method thereof
CN105695258A (en) Female health wine containing lychee seed saponin
CN101724667A (en) Technology for extracting dendrobium polysaccharide by applying biology engineering enzyme technology and product thereof and application
CN104970421A (en) Longan and donkey-hide gelatin powder composite solid drink
KR101234605B1 (en) Manufacturing method of black rootlets of ginseng
CN107333926A (en) A kind of Seabuckthorn healthcare tea and its preparation technology
KR102042798B1 (en) A method for preparing functional pills comprising extracts of natural materials
CN104739977A (en) Maca health wine/tablet with function of strengthening primordial qi
CN107432911B (en) Ginseng buccal tablet for preserving health and tonifying kidney and preparation method thereof
CN112220885A (en) Traditional Chinese medicine composition for protecting gastric mucosa and preparation method and application thereof
CN112704717A (en) Stomach-invigorating medicinal and edible composition for assisting treatment of advanced digestive tract tumor
CN103734767A (en) Health-care food
KR101095357B1 (en) Processed Ginseng
CN110810693A (en) A beverage composition containing Ampelopsis grossedentata and its preparation method
CN101248877A (en) Anti-senescence functional food product and method for preparing the same
KR102436045B1 (en) Fermented black ginseng composition prepared using yeast fermentation broth containing medicinal herbs and minerals and manufacturing method thereof
CN113679051A (en) Peony polypeptide powder, solid beverage and application thereof
CN108355052B (en) Medicine for treating leucopenia after radiotherapy and chemotherapy and preparation method and application thereof
CN112076292A (en) Powder with functions of enhancing immunity and regulating kidney yin deficiency and preparation method thereof
KR101479096B1 (en) Health functional food comprising extracts of herbal mixture for preventing or improving edema of delivered or pregnant woman
CN112402569A (en) Anti-fatigue health product and preparation method thereof

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160212

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20170213

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20180213

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20190212

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20200213

Year of fee payment: 8